Achieve Life Sciences, Inc. Proceeds from Sale of Productive Assets
Achieve Life Sciences, Inc. (ACHV) reported Proceeds from Sale of Productive Assets of $10.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2021-03-11
- Achieve Life Sciences, Inc. proceeds from sale of productive assets for the quarter ending 2018-12-31 was $0.00.
- Achieve Life Sciences, Inc. proceeds from sale of productive assets for the quarter ending 2018-09-30 was $0.00.
- Achieve Life Sciences, Inc. proceeds from sale of productive assets for the quarter ending 2018-06-30 was $0.00.
- Achieve Life Sciences, Inc. proceeds from sale of productive assets for the quarter ending 2018-03-31 was $10.00K.
- Achieve Life Sciences, Inc. proceeds from sale of productive assets for fiscal 2018 was $10.00K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $10.00K 10-K · filed 2021-03-11 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $10.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $10.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $10.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |